Go Pro
NYSE:USNA

USANA Health Sciences (USNA) Stock Price, News & Analysis

USANA Health Sciences logo
$22.64 +0.54 (+2.42%)
As of 02:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About USANA Health Sciences Stock (NYSE:USNA)

Advanced

Key Stats

Today's Range
$22.15
$23.03
50-Day Range
$17.47
$23.22
52-Week Range
$16.60
$32.32
Volume
46,935 shs
Average Volume
119,296 shs
Market Capitalization
$418.09 million
P/E Ratio
48.19
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

USANA Health Sciences, Inc. is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America. Key regions of operation include the United States, Canada, China, Taiwan, Australia, the United Kingdom and Mexico. The company leverages a multilevel marketing structure, enabling independent distributors to earn commissions on personal sales and the sales of their recruited team members.

USANA’s manufacturing facilities are located in Salt Lake City, Utah, and in Tlalnepantla, Mexico, providing global production capacity to support demand. The company has emphasized scientific validation of its products and maintains partnerships with third‐party research institutions. Through its focus on health sciences and peer‐reviewed studies, USANA positions itself as a science‐driven provider of wellness solutions.

AI Generated. May Contain Errors.

USANA Health Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
39th Percentile Overall Score

USNA MarketRank™: 

USANA Health Sciences scored higher than 39% of companies evaluated by MarketBeat, and ranked 123rd out of 171 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    USANA Health Sciences has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    USANA Health Sciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about USANA Health Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for USANA Health Sciences are expected to grow by 30.66% in the coming year, from $2.12 to $2.77 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of USANA Health Sciences is 48.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 40.27.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of USANA Health Sciences is 48.59, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 14.53.

  • Price to Earnings Growth Ratio

    USANA Health Sciences has a PEG Ratio of 0.87. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    USANA Health Sciences has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about USANA Health Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    4.11% of the float of USANA Health Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    USANA Health Sciences has a short interest ratio ("days to cover") of 8.64.
  • Change versus previous month

    Short interest in USANA Health Sciences has recently increased by 14.14%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    USANA Health Sciences does not currently pay a dividend.

  • Dividend Growth

    USANA Health Sciences does not have a long track record of dividend growth.

  • News Sentiment

    USANA Health Sciences has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for USANA Health Sciences this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $336,579.00 in company stock.

  • Percentage Held by Insiders

    0.82% of the stock of USANA Health Sciences is held by insiders.

  • Percentage Held by Institutions

    54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about USANA Health Sciences' insider trading history.
Receive USNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

USNA Stock News Headlines

A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
Why USANA (USNA) stock is up today
See More Headlines

USNA Stock Analysis - Frequently Asked Questions

USANA Health Sciences' stock was trading at $19.61 at the beginning of 2026. Since then, USNA shares have increased by 16.4% and is now trading at $22.8250.

USANA Health Sciences, Inc. (NYSE:USNA) issued its quarterly earnings results on Tuesday, May, 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.44 by $0.17. The company earned $250.22 million during the quarter, compared to the consensus estimate of $240.99 million. USANA Health Sciences had a net margin of 0.96% and a trailing twelve-month return on equity of 6.21%.
Read the conference call transcript
.

Top institutional investors of USANA Health Sciences include Assenagon Asset Management S.A. (0.21%) and Versant Capital Management Inc (0.01%). Insiders that own company stock include Myron W Wentz, Jim Brown, Kevin Guest, David Mulham Mulham, Frederic J Winssinger, John Turman Fleming, Peggie Pelosi, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig.
View institutional ownership trends
.

Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX).

Company Calendar

Last Earnings
5/05/2026
Today
8/03/2026
Next Earnings (Confirmed)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Personal Care Products
Sub-Industry
Personal Care Products
Current Symbol
NYSE:USNA
CIK
896264
Employees
1,570
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
$0.47
Trailing P/E Ratio
48.19
Forward P/E Ratio
10.68
P/E Growth
0.87
Net Income
$10.76 million
Net Margins
0.96%
Pretax Margin
4.35%
Return on Equity
6.21%
Return on Assets
4.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.51
Quick Ratio
1.69

Sales & Book Value

Annual Sales
$925.94 million
Price / Sales
0.45
Cash Flow
$4.23 per share
Price / Cash Flow
5.35
Book Value
$29.16 per share
Price / Book
0.78

Miscellaneous

Outstanding Shares
18,463,000
Free Float
18,312,000
Market Cap
$418.11 million
Optionable
Optionable
Beta
0.73

Social Links

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:USNA) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners